VG-302

N/A

Report date: 2024/04/28 14:15:40

Base Information

Drug NameVG-302
Drug Alias NameVG-302
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionCell death stimulantsImmunologic cytotoxicityInterleukin-12 stimulants +[5] 
TargetsInterleukin-12Interleukin-15Interleukin-15 receptor subunit alpha
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVirogin Biotech Canada Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVirogin Biotech Canada Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A